These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 36547591)

  • 41. Merits and pitfalls of currently used diagnostic tools in mycetoma.
    van de Sande WW; Fahal AH; Goodfellow M; Mahgoub el S; Welsh O; Zijlstra EE
    PLoS Negl Trop Dis; 2014 Jul; 8(7):e2918. PubMed ID: 24992636
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mycetoma caused by Microascus gracilis: a novel agent of human eumycetoma in Sudan.
    Mhmoud NA; Siddig EE; Nyuykonge B; Bakhiet SM; van de Sande WWJ; Fahal AH
    Trans R Soc Trop Med Hyg; 2021 Apr; 115(4):426-430. PubMed ID: 33515449
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular identification of Actinomadura madurae isolated from a patient originally from Algeria; observations from a case report.
    Izri A; Aljundi M; Billard-Pomares T; Fofana Y; Marteau A; Ferreira TG; Brun S; Caux F; Akhoundi M
    BMC Infect Dis; 2020 Nov; 20(1):829. PubMed ID: 33176717
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A painful thorn in the foot: a case of eumycetoma.
    Rouphael NG; Talati NJ; Franco-Paredes C
    Am J Med Sci; 2007 Aug; 334(2):142-4. PubMed ID: 17700208
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Role of Interleukin-1 cytokine family (IL-1β, IL-37) and interleukin-12 cytokine family (IL-12, IL-35) in eumycetoma infection pathogenesis.
    Abushouk A; Nasr A; Masuadi E; Allam G; Siddig EE; Fahal AH
    PLoS Negl Trop Dis; 2019 Apr; 13(4):e0007098. PubMed ID: 30946748
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mycetoma imaging: the best practice.
    Bahar ME; Bakheet OELH; Fahal AH
    Trans R Soc Trop Med Hyg; 2021 Apr; 115(4):387-396. PubMed ID: 33537774
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The developed molecular biological identification tools for mycetoma causative agents: An update.
    Siddig EE; Verbon A; Bakhiet S; Fahal AH; van de Sande WWJ
    Acta Trop; 2022 Jan; 225():106205. PubMed ID: 34687643
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The in vitro antifungal activity of sudanese medicinal plants against Madurella mycetomatis, the eumycetoma major causative agent.
    Elfadil H; Fahal A; Kloezen W; Ahmed EM; van de Sande W
    PLoS Negl Trop Dis; 2015 Mar; 9(3):e0003488. PubMed ID: 25768115
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nocardiosis in Sudan: Current Situation and Future Perspective.
    Elhassan MM
    Infect Disord Drug Targets; 2019; 19(2):105-112. PubMed ID: 30207249
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rapid and Robust Identification of the Agents of Black-Grain Mycetoma by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry.
    Fraser M; Borman AM; Johnson EM
    J Clin Microbiol; 2017 Aug; 55(8):2521-2528. PubMed ID: 28592546
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mycetoma: a unique neglected tropical disease.
    Zijlstra EE; van de Sande WWJ; Welsh O; Mahgoub ES; Goodfellow M; Fahal AH
    Lancet Infect Dis; 2016 Jan; 16(1):100-112. PubMed ID: 26738840
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Mycetoma in Somalia - results of a survey done from 1959 to 1964].
    Destombes P; Mariat F; Rosati L; Segretain G
    Acta Trop; 1977 Dec; 34(4):355-73. PubMed ID: 23657
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mycetoma and Chromoblastomycosis: Perspective for Diagnosis Improvement Using Biomarkers.
    Bienvenu AL; Picot S
    Molecules; 2020 Jun; 25(11):. PubMed ID: 32498471
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Orbital mycetoma: a case report].
    Gueye NN; Seck SM; Diop Y; Ndiaye Sow MN; Agboton G; Diakhaté M; Dieng M; Dieng MT
    J Fr Ophtalmol; 2013 May; 36(5):435-41. PubMed ID: 23357551
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mycetoma in the Sudan: an update from the Mycetoma Research Centre, University of Khartoum, Sudan.
    Fahal A; Mahgoub el S; El Hassan AM; Abdel-Rahman ME
    PLoS Negl Trop Dis; 2015 Mar; 9(3):e0003679. PubMed ID: 25816316
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The use of traditional medicines among mycetoma patients.
    Kunna E; Yamamoto T; Fahal A
    Trans R Soc Trop Med Hyg; 2021 Apr; 115(4):297-306. PubMed ID: 33247308
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mycetoma: The Spectrum of Clinical Presentation.
    Fahal AH; Suliman SH; Hay R
    Trop Med Infect Dis; 2018 Sep; 3(3):. PubMed ID: 30274493
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Microsporum canis mycetoma of the scalp].
    Vezon G; Desbois N; Boisseau-Garsaud AM; Helenon R; Jouannelle A; Saint-Cyr I; Cales-Quist D
    Ann Dermatol Venereol; 2000; 127(8-9):729-31. PubMed ID: 11011164
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Madurella mycetomatis infection of the buttock in an Eritrean refugee in Switzerland: a case report.
    Mekoguem C; Triboulet C; Gouveia A
    J Med Case Rep; 2019 Feb; 13(1):32. PubMed ID: 30755254
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mycetoma: Nonvenereal perineal lesions.
    Gupta S; Jain K; Parmar C; Shah P; Raval RC
    Indian J Sex Transm Dis AIDS; 2010 Jan; 31(1):39-41. PubMed ID: 21808436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.